Related Experiment Video
Updated: Jul 19, 2026
09:14
An In Vitro System to Study Tumor Dormancy and the Switch to Metastatic Growth
Published on: August 11, 2011
[Development of research on tumor dormancy].
Guo-Wei Che1, Lun-Xu Liu, Qing-Hua Zhou
1Department of Cardiovascular Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China. cheguowei@yahoo.com.cn
AI Zheng = Aizheng = Chinese Journal of Cancer
|October 25, 2006
Summary
Tumor dormancy, a state where cancer cells persist without growing, drives treatment failure and recurrence. Understanding its mechanisms is key to developing new therapies that target dormant cancer cells.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tumor dormancy is a critical factor in cancer treatment failure, metastasis, and recurrence.
- Understanding the biological characteristics and molecular mechanisms of tumor dormancy is essential for effective cancer therapy.
Purpose of the Study:
- To review the evidence of tumor dormancy in patients.
- To discuss the evolution of the definition and animal models of tumor dormancy.
- To summarize recent advancements in targeting tumor dormancy with novel antitumor drugs.
Main Methods:
- Literature review of studies on tumor dormancy.
- Analysis of the definition and establishment of animal models for tumor dormancy.
- Synthesis of recent research on molecular mechanisms and therapeutic strategies.
Main Results:
- Tumor dormancy is a recognized phenomenon in patients with malignant tumors.
- Established animal models and evolving definitions aid in studying tumor dormancy.
- Novel therapeutic strategies are emerging to target dormant tumor cells.
Conclusions:
- Tumor dormancy presents a significant challenge in cancer treatment, leading to recurrence and metastasis.
- Further research into the molecular underpinnings of tumor dormancy is crucial.
- Targeting tumor dormancy holds promise for developing more effective cancer therapies.
More Related Videos
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
12:48A Time-lapse, Label-free, Quantitative Phase Imaging Study of Dormant and Active Human Cancer Cells
Published on: February 16, 2018
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...